Multi-panel drugs detection in human serum for personalized therapy

Biosensors and Bioelectronics

Volumn 26, Issue 9, 2011, Pages 3914-3919

  Carrara, Sandro ^a   Cavallini, Andrea ^a   Erokhin, Victor ^b   De Micheli, Giovanni ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Carbon nanotubes; Cytochromes P450; Drugs detection; Multi drug detection; Personalized therapy

Indexed keywords

COMPETITIVE KINETICS; CYTOCHROMES P450; DATA ANALYSIS; DETECTION LIMITS; DEXTROMETHORPHAN; DRUG DETECTION; DRUGS DETECTION; ENHANCED SENSITIVITY; FLURBIPROFEN; HUMAN SERUM; ISOFORMS; LIMIT OF DETECTION; MULTI-DRUG DETECTION; NAPROXENS; NEW APPROACHES; NEW MATHEMATICAL MODEL; PERSONALIZED THERAPY; REDUCTION PEAK; WORK FOCUS;

BIOSENSORS; BODY FLUIDS; DATA REDUCTION; DRUG THERAPY; MATHEMATICAL MODELS;

MULTIWALLED CARBON NANOTUBES (MWCN);

BENZPHETAMINE; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2B4; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; FLURBIPROFEN; MULTI WALLED NANOTUBE; NAPROXEN; CARBON NANOTUBE; CYTOCHROME P-450 CYP2B4 (RABBIT); CYTOCHROME P450 3A; UNSPECIFIC MONOOXYGENASE;

ARTICLE; BIOSENSOR; BLOOD ANALYSIS; DRUG DETERMINATION; DRUG MIXTURE; LIMIT OF DETECTION; MATHEMATICAL MODEL; PERSONALIZED MEDICINE; SENSITIVITY AND SPECIFICITY; CHEMISTRY; GENETIC PROCEDURES; HUMAN; ISOLATION AND PURIFICATION;

ARYL HYDROCARBON HYDROXYLASES; BENZPHETAMINE; BIOSENSING TECHNIQUES; CYCLOPHOSPHAMIDE; CYTOCHROME P-450 CYP2C9; CYTOCHROME P-450 CYP3A; HUMANS; LIMIT OF DETECTION; NANOTUBES, CARBON; NAPROXEN;

EID: 79955481638     PISSN: 09565663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bios.2011.03.009     Document Type: Article

References (33)

1. Abramoff M.D., Magelhaes P.J., Ram S.J. Biophotonics Int. 2004, 11:36-42.
2. Aspinall M., Hamermesh R. Harv. Bus Rev. 2007, 85(10):108-117.
3. Bard A.J., Faulkner L.R. Electrochemical Methods-Fundamental and Applications 2001, John Wiley & Sons, New York, Equation (6.2.18) at page 231. Second edition.
4. Boero C., Carrara S., De Micheli G. Proceedings of IEEE/PRIME 2009 5th Conference on PhD Research in Microelectronics and Electronics 2009, 72-75.
5. Carrara C., Bavastrello V., Ricci D., Stura E., Nicolini C. Sens. Actuators B 2005, 109:221-226.
6. Carrara S., Shumyantseva V., Archakov A., Samorì B. Biosens. Bioelectron. 2008, 24(1):148-150.
7. Carrara S., Cavallini A., Garg A., De Micheli G. Proceedings of the IEEE/ICME International Conference on Complex Medical Engineering 2009, 1-6.
8. Daly A. Curr. Opin. Drug Discov. 2007, 10(1):29-36.
9. De Leon J., Susce M., Murray-Carmichael E. Mol. Diagn. Ther. 2006, 10(3):135-151.
10. Eichelbaum M., Somogyi A., Unruh G., Dengler H. Eur. J. Clin. Pharmacol. 1981, 19(2):133-137.
11. Frank D., Jaehde U., Fuhr U. Eur J. Clin. Pharmacol. 2007, 63(4):321-333.
12. Hammersley J.M., Handscomb D.C. Monte Carlo Methods 1975, Fletcher & Son Publisher, Norwich (UK), first edition in 1964, reprinted in 1975.
13. Iwuoha E., Ngece R., Klink M., Baker P. IET Nanobiotechnol. 2007, 1(4):62-67.
14. Johnson D., Lewis B., Elliot D., Miners J., Martin L. Biochem. Pharmacol. 2005, 69(10):1533-1541.
15. Joseph S., Rusling J., Lvov Y., Friedberg T., Fuhr U. Biochem. Pharmacol. 2003, 65(11):1817-1826.
16. Juma F.D., Rogers H.J., Trounce J.R. Br J. Clin. Pharm. 1979, 8:209-217.
17. Kashuba A., Bertino J. Drug Interactions in Infectious Diseases 2003, 13-39. Humana Press, Totowa, USA. 1st ed. S. Piscitelli, K.A. Rodvold (Eds.).
18. Kiselyova O., Yaminsky I., Ivanov Y., Kanaeva I., Kuznetsov V., Archakov A. Arch. Biochem. Biophys. 1999, 371(1):1-7.
19. Korzekwa K.R., Krishnamachary N., Shou M., Ogai A., Parise R.A., Rettue A.E., Gonzales F.J., Tracy T.S. Biochemistry 1998, 37:4137-4147.
20. Lazarou J., Pomeranz B., Corey P. Jama 1998, 279(15):1200.
21. Lin J. Curr. Drug Metab. 2007, 8(2):109-136.
22. Liu S., Peng L., Yang X., Wu Y., He L. Anal. Biochem. 2008, 375(2):209-216.
23. Locuson C.W., Tracy T.S. Drug Metab. Dispos, 2006, 34(12):1954-1957.
24. Mc Naught A.D., Wilkinson A. IUPAC. Compendium of Chemical Terminology 2nd ed. (the "Gold Book") 1997, Blackwell Scientific Publications, Oxford.
25. Naka T., Sakamoto N. J. Membr. Sci. 1992, 74:159-170.
26. Peng L., Yang X., Zhang Q., Liu S. Electroanalysis 2008, 20(7):803-807.
27. Schepers R., Oyler J., Joseph R., Cone E., Moolchan E., Huestis M. Clin. Chem. 2003, 49(1):121.
28. Shumyantseva V., Carrara S., Bavastrello V., Jason Riley D., Bulko T., Skryabin K., Archakov A., Nicolini C. Biosens. Bioelectron. 2005, 21(1):217-222.
29. Shumyantseva V.V., Bulko T.V., Rudakov Y.O., Kuznetsova G.P., Samenkova N.F., Lisitsa A.V., Karuzina I.I., Archakov A.I. J. Inorg. Biochem. 2007, 101(5):859-865.
30. Struck R., Alberts D., Horne K., Phillips J., Peng Y., Roe D. Cancer Res. 1987, 47(10):2723-2726.
31. Tracy T.S. Curr. Drug Metab. 2003, 4:341-346.
32. Turner S., Schwartz G., Boerwinkle E. Hypertension 2007, 50(1):1-5.
33. Yano J.K., Wester M.R., Schoch G.A., Griffin K.J., Stout C.D., Johnson E.F. J. Biol. Chem. 2004, 279:38091-38094.